Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulse Steroid and IVIG in Severe COVID-19
NCT06223984Phase 4Completed
- Sponsor
- Konya City Hospital
- Start
- Mar 2020
- Primary completion
- Nov 2020
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of methylprednisolone, immune globulin in coronavirus disease 2019 (COVID-19), sponsored by Konya City Hospital. Started Mar 2020; status: completed.
02
Drugs
methylprednisoloneimmune globulin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT06223984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06223984.